| ALL | acute lymphoblastic leukemia |
| ATM | ataxia telangiectasia mutated |
| ATR | ataxia telangiectasia and rad3-related protein |
| BER | base-excision repair |
| BRCA | breast-related cancer antigens |
| CA-125 | cancer antigen 125 |
| DDR | DNA damage response |
| DSBs | double-strand breaks |
| eIF4E | eukaryotic translation initiation factor 4E |
| EOC | epithelial ovarian cancer |
| ER | estrogen receptor |
| HER2 | human epidermal growth factor receptor 2 |
| HGSOC | high-grade serous ovarian cancer |
| HR | homologous recombination DNA repair |
| HRD | homologous recombination DNA repair deficiency |
| IGF-R | insulin-like growth factor receptor |
| LGSOC | low-grade serous ovarian cancer |
| MAPK | mitogen-activated protein kinase |
| MEK | MAPK/ERK kinase |
| mTOR | mammalian target of rapamycin |
| mTORC1 | mammalian target of rapamycin complex 1 |
| MDM2 | murine double minute 2 |
| MYC | v-myc avian myelocytomatosis viral oncogene homolog |
| OC | ovarian cancer |
| PARP | poly ADP-ribose polymerase |
| PDX | patient-derived xenograft |
| PI3K | phosphatidylinositol-3-kinase |
| Pol I | RNA polymerase I |
| Pol II | RNA polymerase II |
| Pol III | RNA polymerase III |
| PTEN | phosphatase and tensin homolog |
| RAS | retrovirus-associated DNA sequences |
| rDNA | ribosomal DNA |
| rRNA | ribosomal RNA |
| RPs | ribosomal proteins |
| SL-1 | selectivity factor 1 |
| TERT | telomerase reverse transcriptase |
| UBF | upstream binding factor |
| VEGF | vascular endothelial growth factor |